Hooman Sazegar
- Oncology top 2%
- HER2/EGFR in Cancer Research 2
- Cancer Immunotherapy and Biomarkers 2
- Cancer-related Molecular Pathways 1
- Cutaneous Melanoma Detection and Management 1
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 4
- PI3K/AKT/mTOR signaling in cancer 2
- Immunology top 10%
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Cancer Research top 10%
- Co-authors
- Antoni RibasRichard C. KoyaNarsis AttarRoger S. LoThinle ChodonRamin NazarianQi WangHubing Shi
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Hooman Sazegar
7 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 1.2k
- Molecular Biology 1.7k
- Computational Theory and Mathematics 328
- Immunology 326
- Cancer Research 229
Countries citing papers authored by Hooman Sazegar
This map shows the geographic impact of Hooman Sazegar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hooman Sazegar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hooman Sazegar more than expected).
Fields of papers citing papers by Hooman Sazegar
This network shows the impact of papers produced by Hooman Sazegar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hooman Sazegar. The network helps show where Hooman Sazegar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hooman Sazegar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 14 | |
| 2 | 2011 | 120 | |
| 3 | 2011 | 78 | |
| 4 | Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationbreakdown → | 2010 | 1614 |
| 5 | 2010 | 23 | |
| 6 | 2010 | 171 | |
| 7 | 2010 | 111 |
About Hooman Sazegar
Hooman Sazegar is a scholar working on Oncology, Immunology and Computational Theory and Mathematics, having authored 7 papers that have together received 2.1k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Immunotherapy and Immune Responses (3 papers), HER2/EGFR in Cancer Research (2 papers), T-cell and B-cell Immunology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer-related Molecular Pathways (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Oncology (1.2k citations), Molecular Biology (1.7k citations) and Computational Theory and Mathematics (328 citations). Hooman Sazegar has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Antoni Ribas, Richard C. Koya, Narsis Attar, Roger S. Lo, Thinle Chodon, Ramin Nazarian, Qi Wang, Hubing Shi, Mi‐Kyung Lee and Stanley F. Nelson. Their work appears in journals such as Nature, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.